Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial

被引：0

作者：

Marona, Jose ^{[1
,2
]}

Rodrigues-Manica, Santiago ^{[3
]}

Gomes, Joao Lagoas ^{[1
,2
]}

Lopes, Carina ^{[1
,2
]}

Iria, Ines ^{[4
]}

Bernardes, Miguel ^{[5
]}

Santos, Helena ^{[6
]}

Tavares-Costa, Jose ^{[7
]}

Madruga-Dias, Joao ^{[8
]}

Pinto, Patricia ^{[9
]}

Bernardo, Alexandra ^{[10
]}

Maia, Sara ^{[2
]}

Branco, Jaime ^{[3
]}

Goncalves, Joao ^{[4
]}

Pimentel-Santos, Fernando ^{[3
]}

机构：

[1] Hosp Egas Moniz, Rheumatol Dept, Ctr Hosp Lisboa Ocidental, Lisbon, Portugal

[2] NOVA Med Sch, Fac Ciencias Med, CEDOC, Lisbon, Portugal

[3] Hosp Egas Moniz, NOVA Med Sch, CEDOC, CHLO, Lisbon, Portugal

[4] Univ Lisbon, Fac Farm, Lisbon, Portugal

[5] Ctr Hosp Sao Joao, Rheumatol, Porto, Portugal

[6] IPR, Lisbon, Portugal

[7] ULSAM, Ponte do Lima, Portugal

[8] CHMT, Torres Novas, Portugal

[9] CHVNG, Rheumatol Dept, Vila Nova De Gaia, Portugal

[10] CHSJ, Rheumatol Dept, Porto, Portugal

来源：

ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0586

引用

页数：2

共 50 条

[41] Adalimumab/golimumab/infliximabCytomegalovirus infection, development of anti-drug antibodies and lack of efficacy: case report
[J]. Reactions Weekly, 2021, 1885 (1) : 28 - 28
[42] Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease
Strik, A. S.
van den Brink, G. R.
Ponsioen, C.
Mathot, R.
Loewenberg, M.
D'Haens, G. R.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (08) : 1128 - 1134
[43] LOW DRUG CONCENTRATIONS AND ANTI-DRUG ANTIBODY FORMATION TO THE PRIOR ANTI-TNF PREDISPOSES PATIENTS WITH INFLAMMATORY BOWEL DISEASE TO DEVELOP ANTI-DRUG ANTIBODIES TO THE SUBSEQUENT ANTI-TNF
Cheifetz, Adam S.
Abreu, Maria T.
Flier, Sarah N.
Papamichail, Konstantinos
Rieder, Florian
Silverberg, Mark S.
Khanna, Reena
Okada, Lauren
Yang, Lei
Jain, Anjali
Vande Casteele, Niels
[J]. GASTROENTEROLOGY, 2020, 158 (06) : S457 - S457
[44] Rituximab in multiple sclerosis; frequency and clinical relevance of anti-drug antibodies
Dunn, Nicky
Juto, Alexander
Ryner, Malin
Manouchehrinia, Ali
Piccoli, Luca
Fink, Katharina
Piehl, Fredrik
Fogdell-Hahn, Anna
[J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 342 - 343
[45] RituximabSevere infusion reaction and anti-drug antibodies
[J]. Reactions Weekly, 2023, 1985 (1) : 465 - 465
[46] InfliximabFormation of anti-drug antibodies: case report
[J]. Reactions Weekly, 2022, 1918 (1) : 270 - 270
[47] Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
Dunn, Nicky
Juto, Alexander
Ryner, Malin
Manouchehrinia, Ali
Piccoli, Luca
Fink, Katharina
Piehl, Fredrik
Fogdell-Hahn, Anna
[J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (09) : 1224 - 1233
[48] Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody
Schick, Arthur J., III
Lundin, Victor
Low, Justin
Peng, Kun
Vandlen, Richard
Wecksler, Aaron T.
[J]. MABS, 2022, 14 (01)
[49] DETECTING ADALIMUMAB SERUM LEVEL AND ANTI-DRUG ANTIBODIES - FUTURE TOOL IN MONITORING SPONDYLOARTHRITIS PATIENTS?
Deaconu, C.
Opris, D.
Mazilu, D.
Borangiu, A.
Groseanu, L.
Negru, M.
Constantinescu, C.
Saulescu, I.
Bojinca, V.
Vlad, V.
Balanescu, A.
Predeteanu, D.
Ionescu, R.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A75 - A75
[50] Anti-drug antibodies in the current management of cancer
Miguel Borregón
Katherine Martínez
Alba Ramos
Irene Ramos
Beatriz Berzal
Manuel Mazariegos
Elia Martínez
Tatiana Hernández
Bernard Doger
Víctor Moreno
[J]. Cancer Chemotherapy and Pharmacology, 2022, 89 : 577 - 584

← 1 2 3 4 5 →